Study on the efficiency of speeding hematopoiesis technology in improving the adaptability of rapid entry to high altitude

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100043844

Enrollment

Unknown

Registered

2021-03-04

Start date

2021-03-07

Completion date

Unknown

Last updated

2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

AAA group:red blood cell ahperesis

control group:Nil

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: On the basis of blood donation health consultation, healthy volunteers aged 18-40 were selected, male, weight over than 70kg, the pressure blood was 120-140/60-90 mmHg, Pulse pressure difference was over than 30mmHg, the pulse was 60-100bpm. Hemoglobin > 120g/L, platelet > 110 x 10^9/L; the result of blood biochemistry and other examination result were normal.

Exclusion criteria

Exclusion criteria: Abnormal or inhibited hematopoietic function of bone marrow; cardiopulmonary insufficiency; fever or infectious diseases; taking drugs to inhibit compensatory cardiovascular response, such as ß - blockers; taking drugs to promote or inhibit hematopoietic function; blood donation history within half a year (related questionnaire in health consultation).

Design outcomes

Primary

Measure	Time frame
rbc;Hb;cognition;sleep;Physical fitness;	—

Countries

China

Contacts

Public ContactZhang Rong

The Fourth Medical Center of Chinese PLA General Hospital

304shuxueke@sina.com+86 13681562236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026